Hepingxing Cross-border E-commerce (Hangzhou) Co., Ltd. – Trademark Portfolio
Entity Type: 99
Hepingxing Cross-border E-commerce (Hangzhou) Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 27 (Floor Coverings) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include AEVITASX. The owner is based in Zhejiang.
Road,Gongshu District,Hangzhou City
Room 1020,Building 5,No.789 Shixiang
Zhejiang 310000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Hepingxing Cross-border E-commerce (Hangzhou) Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Carpets, rugs, mats and matting, linoleum and other materials for covering floors
Frequently Asked Questions
How many trademarks does Hepingxing Cross-border E-commerce (Hangzhou) Co., Ltd. have?
Hepingxing Cross-border E-commerce (Hangzhou) Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Hepingxing Cross-border E-commerce (Hangzhou) Co., Ltd. file in?
Hepingxing Cross-border E-commerce (Hangzhou) Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 27 (Floor Coverings). Class 27 covers carpets, rugs, mats and matting, linoleum and other materials for covering floors.
What are Hepingxing Cross-border E-commerce (Hangzhou) Co., Ltd.'s most well-known trademarks?
Hepingxing Cross-border E-commerce (Hangzhou) Co., Ltd.'s registered trademark portfolio includes well-known marks such as AEVITASX. These are among 1 currently registered trademark in the portfolio.
What is Hepingxing Cross-border E-commerce (Hangzhou) Co., Ltd.'s trademark registration success rate?
Hepingxing Cross-border E-commerce (Hangzhou) Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.